FIPRecover News │ Feline Antiviral Industry Updates

FIPRecover Announces Expansion of Production Capacity to Meet Growing Demand for FIP Therapies

Our mission is to give every cat with FIP a fighting chance

11th December 2025

Pioneering Precision Therapeutics for Feline Infectious Peritonitis (FIP)

We specialize in the advanced production and supply of GS441524 and Molnupiravir—two antiviral agents clinically proven to combat the FIP virus effectively.

11th December 2025

FIPRecover Biotechnology Co., LTD.

FIPRecover Biotechnology Co., LTD. : Protecting Cats with Technology

Feline infectious peritonitis can be regarded as a “silent killer” threatening the lives of cats. This disease silently poses a threat to the lives of cats. To address the challenges brought by feline infectious peritonitis, FIPRecover Biotechnology Co., Ltd. has devoted all its energy to the research and development of pet disease treatment. It takes biotechnology as its core I want to bring new hope to those cats suffering from FIP.

As a professional company in the field of pet biopharmaceuticals, the company’s core business mainly focuses on the highly effective drug GS441524 and Molnupiravir. Clinically proven, this drug can precisely target the pathogenesis of FIP, inhibit viral replication, reduce inflammation, and help cats overcome adverse symptoms such as fever and ascites. From raw material procurement to every stage of production and processing, the company strictly controls every link, always adhering to international standards. With very meticulous quality control, it ensures the safety, efficacy and stability of the drugs, building a solid defense line against the side effects of the drugs.

The company’s mission is “to alleviate the suffering of kittens with fip and give them a new lease of life.” The company has gathered a team composed of experienced veterinarians and R&D experts to provide free disease consultation, medication guidance, and rehabilitation follow-up services for pet owners. The company collaborates with relevant organizations to carry out public health education, enabling FIP knowledge to be more widely popularized and improving the network for cat health protection. In the future, The company will continue to deepen its development in the field of pet biomedicine, using outstanding technology, products and services to safeguard the health of cats around the world, enabling more kittens to stay away from diseases and enjoy happy times to the fullest.

+8615898659128

shirley@fiprecover.com

FIPRecover Announces Expansion of Production Capacity to Meet Growing Demand for FIP Therapies

Pioneering Precision Therapeutics for Feline Infectious Peritonitis (FIP)

Products

News

CONTACT US